TRIB News and Press, Trinity Biotech plc From 11/03/22

DUBLIN, Ireland, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended June 30, 2022 and prel...

DUBLIN, Ireland, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2022 on Thursday, Novemb...

DUBLIN, Ireland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces the appointment of Mr. Tom Lindsay to its Board of Directors as an indepe...

Summary We are bullish on the at-home testing healthcare market but bearish for retail value investors on Fulgent Genetics until growth and momentum improve. They reported revenue growth and profits, hold a lot of cash, but face a year of possible slowing revenue and significantly...

Trinity Biotech ( NASDAQ: TRIB ) on Monday said it had appointed Aris Kekedjian as its CEO, succeeding co-founder Ronan O’Caoimh. Kekedjian had also been named chairman of the company's board, TRIB said in a statement . According to TRIB, Kekedjian...

DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the appointment of Mr. Aris Kekedjian as CEO with effect from October 3, ...

DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Annual General Meeting (AGM). A GM Results...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another breakdown of the biggest pre-market stock movers and the news moving them on Wednesday! We’ve got a SPAC merger, special shareholder meetings, st...

Trinity Biotech plc (TRIB) Q1 2022 Earnings Conference Call June 30, 2022, 11:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Ronan O’Caoimh - Chairman and Chief Executive Officer John Gillard - Chief Financial Officer and Director Confe...

Trinity Biotech press release ( NASDAQ: TRIB ): Q1 GAAP EPADS of -50c. Revenue of $18.78M (-26.6% Y/Y) misses by $1.22M . For further details see: Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M